Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present CAS Medical Systems, Inc. (NASDAQ: CASM).

Full DD Report for CASM

You must become a subscriber to view this report.


Recent News from (NASDAQ: CASM)

FDA Clears CASMED's FORE-SIGHT Tissue Oximetry OEM Module
BRANFORD, Conn., May 16, 2018 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (NASDAQ:CASM) (CASMED), a leader in medical products for non-invasive patient monitoring of tissue oxygenation, announces receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its FORE-S...
Source: GlobeNewswire
Date: May, 16 2018 08:00
CAS Medical Systems' (CASM) CEO Tom Patton on Q1 2018 Results - Earnings Call Transcript
CAS Medical Systems, Inc. (CASM) Q1 2018 Earnings Conference Call May 10, 2018 10:00 AM ET Executives Jody Cain – Senior Vice President of Investor Relations, Lippert/Heilshorn & Associates, Inc. Tom Patton – President and Chief Executive Officer Jeff Baird ...
Source: SeekingAlpha
Date: May, 11 2018 23:50
CASMED Reports First-Quarter 2018 Financial Results
FORE-SIGHT sales increase 22%; U.S. FORE-SIGHT sales increase 21% Company raises 2018 U.S. and international FORE-SIGHT sales guidance Conference Call Begins at 10:00 a.m. Eastern Time Today BRANFORD, Conn., May 10, 2018 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (NASDAQ:C...
Source: GlobeNewswire
Date: May, 10 2018 08:00
CASMED to Report First-Quarter 2018 Financial Results and Hold Conference Call on May 10
BRANFORD, Conn., May 03, 2018 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (NASDAQ:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, announces that it will report financial results for the first quarter of 2018 on Thursday, May 10.  Management will h...
Source: GlobeNewswire
Date: May, 03 2018 08:00
CAS Medical Systems' (CASM) CEO Thomas Patton on Q4 2017 Results - Earnings Call Transcript
CAS Medical Systems, Inc. (CASM) Q4 2017 Earnings Conference Call March 14, 2018, 10:00 ET Executives Jody Cain - IR Thomas Patton - CEO, President and Director Jeffery Baird - CFO and Secretary Analysts Matthew Hewitt - Craig-Hallum Capital Group Brian Marckx - Zacks In...
Source: SeekingAlpha
Date: March, 14 2018 14:52
CAS Medical Systems reports Q4 results
CAS Medical Systems (NASDAQ: CASM ): Q4 EPS of -$0.07 More news on: CAS Medical Systems, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: March, 14 2018 08:07
CASMED Reports 2017 Fourth-Quarter and Full-Year Financial Results
U.S. FORE-SIGHT sales increased 18% in Q4 on record 80 placements Conference Call Begins Today at 10:00 a.m. Eastern Time BRANFORD, Conn., March 14, 2018 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (NASDAQ:CASM) (CASMED), a leader in medical products for non-invasive patient mo...
Source: GlobeNewswire
Date: March, 14 2018 08:00
CASMED to Report Fourth-Quarter and 2017 Full-Year Financial Results and Hold Conference Call on March 14
BRANFORD, Conn., March 07, 2018 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (NASDAQ:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, announces that it will report financial results for the fourth quarter and full-year 2017 on Wednesday, March 14.  Ma...
Source: GlobeNewswire
Date: March, 07 2018 08:00
CASMED Submits FORE-SIGHT® OEM Module 510(k) to FDA
BRANFORD, Conn., Jan. 24, 2018 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (NASDAQ:CASM) (CASMED), a leader in non-invasive cerebral oximetry patient monitoring, announces that it has submitted a 510(k) application to the U.S. Food and Drug Administration (FDA) for the FORE-SIGHT Tissue O...
Source: GlobeNewswire
Date: January, 24 2018 08:00
CASMED reports preliminary Q4 revenue; shares +14%
CAS Medical Systems (NASDAQ: CASM ) expects net sales from continuing operations for the Q417 to be ~$5.1M (+11% Y/Y) vs. a consensus of $4.53M. Net sales for the FY17 are expected to ~$18.7M (flat Y/Y) vs. a consensus of $18.46M. The Company’s year-end cash balance plus cash avai...
Source: SeekingAlpha
Date: January, 04 2018 12:01

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-08-162.002.122.131.99161,326
2018-08-152.231.98992.301.98711,477
2018-08-142.402.332.50672.32284,649
2018-08-132.662.392.69652.231631,497
2018-08-102.692.662.702.66242,719

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-157,978204,9393.8929Cover
2018-08-14203110,9000.1830Cover
2018-08-1321,961214,64910.2311Cover
2018-08-1031,28996,11832.5527Cover
2018-08-0957,757134,93042.8052Short

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on CASM.


About CAS Medical Systems, Inc. (NASDAQ: CASM)

Logo for CAS Medical Systems, Inc. (NASDAQ: CASM)

Not available

 

Contact Information

 

 

Current Management

  • Louis P. Scheps / President, CEO, CFO
  • Louis Celano / Secretary

Current Share Structure

  • Market Cap: $39,332,375 - 05/14/2018
  • Issue and Outstanding: 28,709,763 - 03/22/2018

 


Recent Filings from (NASDAQ: CASM)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 10 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 10 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 08 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 26 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: April, 26 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: March, 26 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 14 2018
Statement of beneficial ownership of common stock by certain persons
Filing Type: SC 13GFiling Source: edgar
Filing Date: February, 14 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 14 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 14 2018

 

 


Daily Technical Chart for (NASDAQ: CASM)

Daily Technical Chart for (NASDAQ: CASM)


Stay tuned for daily updates and more on (NASDAQ: CASM)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: CASM)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in CASM is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of CASM and does not buy, sell, or trade any shares of CASM. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/